In Treatment

In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
,
,
,
,
GRACE has partnered with Clinical Care Options (CCO) Oncology, to share a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).
Cancer Journey:
Cancer Type:
,
,
,
,
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer...
Cancer Journey:
Cancer Type:
GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving...
Disease Learning:

Articles

Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Cancer Type:
Disease Learning:
Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Cancer Type:
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
Cancer Type:
Disease Learning:
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Cancer Type:

Community Forum

Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
Cancer Type:
Hello friends, My mom, (aged 77, Adenocarcinoma NSCLC, Stage 4, EGFR and ALK negative) was diagnosed in 2014, underwent VATS and pleurodesis,...
Cancer Journey:
Cancer Type:
This question is not for a specific patient, it is designed to understand how oncologists would approach this problem. There’s a 50 year old stage...
Cancer Journey:
Cancer Type:
My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
Cancer Type: